1. Home
  2. DCTH vs METC Comparison

DCTH vs METC Comparison

Compare DCTH & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • METC
  • Stock Information
  • Founded
  • DCTH 1988
  • METC 2015
  • Country
  • DCTH United States
  • METC United States
  • Employees
  • DCTH N/A
  • METC N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • METC Coal Mining
  • Sector
  • DCTH Health Care
  • METC Energy
  • Exchange
  • DCTH Nasdaq
  • METC Nasdaq
  • Market Cap
  • DCTH 630.4M
  • METC 514.2M
  • IPO Year
  • DCTH N/A
  • METC 2017
  • Fundamental
  • Price
  • DCTH $13.85
  • METC $10.97
  • Analyst Decision
  • DCTH Strong Buy
  • METC Strong Buy
  • Analyst Count
  • DCTH 4
  • METC 3
  • Target Price
  • DCTH $24.00
  • METC $13.67
  • AVG Volume (30 Days)
  • DCTH 531.5K
  • METC 776.4K
  • Earning Date
  • DCTH 08-04-2025
  • METC 08-06-2025
  • Dividend Yield
  • DCTH N/A
  • METC 4.36%
  • EPS Growth
  • DCTH N/A
  • METC N/A
  • EPS
  • DCTH N/A
  • METC N/A
  • Revenue
  • DCTH $53,850,000.00
  • METC $628,275,000.00
  • Revenue This Year
  • DCTH $155.42
  • METC N/A
  • Revenue Next Year
  • DCTH $37.93
  • METC $25.50
  • P/E Ratio
  • DCTH N/A
  • METC N/A
  • Revenue Growth
  • DCTH 1068.87
  • METC N/A
  • 52 Week Low
  • DCTH $7.17
  • METC $5.90
  • 52 Week High
  • DCTH $18.23
  • METC $14.15
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 37.03
  • METC 61.28
  • Support Level
  • DCTH $15.72
  • METC $10.68
  • Resistance Level
  • DCTH $17.35
  • METC $12.10
  • Average True Range (ATR)
  • DCTH 0.74
  • METC 0.75
  • MACD
  • DCTH -0.40
  • METC 0.16
  • Stochastic Oscillator
  • DCTH 2.23
  • METC 68.52

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: